 | • レポートコード：MRC2-11QY11086 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオ医薬品のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、その他）市場規模、用途別（腫瘍、糖尿病、心血管、血友病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオ医薬品の競争状況、市場シェア ・世界のバイオ医薬品市場：種類別市場規模 2015年-2020年（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、その他） ・世界のバイオ医薬品市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、その他） ・世界のバイオ医薬品市場：用途別市場規模 2015年-2020年（腫瘍、糖尿病、心血管、血友病、その他） ・世界のバイオ医薬品市場：用途別市場規模予測 2021年-2026年（腫瘍、糖尿病、心血管、血友病、その他） ・北米のバイオ医薬品市場分析：米国、カナダ ・ヨーロッパのバイオ医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオ医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオ医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオ医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Amgen、AbbVie、Sanofi-Aventis、Johnson & Johnson、Pfizer、Novo Nordisk、Eli Lilly、Novartis、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
Market Analysis and Insights: Global Biopharmaceutical Market
The global Biopharmaceutical market size is projected to reach US$ 230710 million by 2026, from US$ 214570 million in 2020, at a CAGR of 7.0%% during 2021-2026.
Global Biopharmaceutical Scope and Market Size
Biopharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Market segment by Type, the product can be split into
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other
Market segment by Application, split into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical Revenue
1.4 Market by Type
1.4.1 Global Biopharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Interferon
1.4.4 Erythropoietin
1.4.5 Insulin
1.4.6 Other
1.5 Market by Application
1.5.1 Global Biopharmaceutical Market Share by Application: 2020 VS 2026
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Market Perspective (2015-2026)
2.2 Global Biopharmaceutical Growth Trends by Regions
2.2.1 Biopharmaceutical Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biopharmaceutical Market Growth Strategy
2.3.6 Primary Interviews with Key Biopharmaceutical Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Players by Market Size
3.1.1 Global Top Biopharmaceutical Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical Revenue Market Share by Players (2015-2020)
3.1.3 Global Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biopharmaceutical Market Concentration Ratio
3.2.1 Global Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Revenue in 2019
3.3 Biopharmaceutical Key Players Head office and Area Served
3.4 Key Players Biopharmaceutical Product Solution and Service
3.5 Date of Enter into Biopharmaceutical Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biopharmaceutical Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biopharmaceutical Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biopharmaceutical Market Size (2015-2020)
6.2 Biopharmaceutical Key Players in North America (2019-2020)
6.3 North America Biopharmaceutical Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biopharmaceutical Market Size (2015-2020)
7.2 Biopharmaceutical Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceutical Market Size by Type (2015-2020)
7.4 Europe Biopharmaceutical Market Size by Application (2015-2020)
8 China
8.1 China Biopharmaceutical Market Size (2015-2020)
8.2 Biopharmaceutical Key Players in China (2019-2020)
8.3 China Biopharmaceutical Market Size by Type (2015-2020)
8.4 China Biopharmaceutical Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biopharmaceutical Market Size (2015-2020)
9.2 Biopharmaceutical Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceutical Market Size by Type (2015-2020)
9.4 Japan Biopharmaceutical Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biopharmaceutical Market Size (2015-2020)
10.2 Biopharmaceutical Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceutical Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical Market Size by Application (2015-2020)
11 India
11.1 India Biopharmaceutical Market Size (2015-2020)
11.2 Biopharmaceutical Key Players in India (2019-2020)
11.3 India Biopharmaceutical Market Size by Type (2015-2020)
11.4 India Biopharmaceutical Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biopharmaceutical Market Size (2015-2020)
12.2 Biopharmaceutical Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceutical Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceutical Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Biopharmaceutical Introduction
13.1.4 Roche Revenue in Biopharmaceutical Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Biopharmaceutical Introduction
13.2.4 Amgen Revenue in Biopharmaceutical Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview
13.3.3 AbbVie Biopharmaceutical Introduction
13.3.4 AbbVie Revenue in Biopharmaceutical Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Sanofi-Aventis
13.4.1 Sanofi-Aventis Company Details
13.4.2 Sanofi-Aventis Business Overview
13.4.3 Sanofi-Aventis Biopharmaceutical Introduction
13.4.4 Sanofi-Aventis Revenue in Biopharmaceutical Business (2015-2020)
13.4.5 Sanofi-Aventis Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Biopharmaceutical Introduction
13.5.4 Johnson & Johnson Revenue in Biopharmaceutical Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Biopharmaceutical Introduction
13.6.4 Pfizer Revenue in Biopharmaceutical Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Details
13.7.2 Novo Nordisk Business Overview
13.7.3 Novo Nordisk Biopharmaceutical Introduction
13.7.4 Novo Nordisk Revenue in Biopharmaceutical Business (2015-2020)
13.7.5 Novo Nordisk Recent Development
13.8 Eli Lilly
13.8.1 Eli Lilly Company Details
13.8.2 Eli Lilly Business Overview
13.8.3 Eli Lilly Biopharmaceutical Introduction
13.8.4 Eli Lilly Revenue in Biopharmaceutical Business (2015-2020)
13.8.5 Eli Lilly Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview
13.9.3 Novartis Biopharmaceutical Introduction
13.9.4 Novartis Revenue in Biopharmaceutical Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview
13.10.3 Merck Biopharmaceutical Introduction
13.10.4 Merck Revenue in Biopharmaceutical Business (2015-2020)
13.10.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Biopharmaceutical Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceutical Revenue
Table 3. Ranking of Global Top Biopharmaceutical Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Interferon
Table 7. Key Players of Erythropoietin
Table 8. Key Players of Insulin
Table 9. Key Players of Other
Table 10. Global Biopharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Biopharmaceutical Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Biopharmaceutical Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Biopharmaceutical Market Share by Regions (2015-2020)
Table 14. Global Biopharmaceutical Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Biopharmaceutical Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Biopharmaceutical Market Growth Strategy
Table 20. Main Points Interviewed from Key Biopharmaceutical Players
Table 21. Global Biopharmaceutical Revenue by Players (2015-2020) (Million US$)
Table 22. Global Biopharmaceutical Market Share by Players (2015-2020)
Table 23. Global Top Biopharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical as of 2019)
Table 24. Global Biopharmaceutical by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biopharmaceutical Product Solution and Service
Table 27. Date of Enter into Biopharmaceutical Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 30. Global Biopharmaceutical Market Size Share by Type (2015-2020)
Table 31. Global Biopharmaceutical Revenue Market Share by Type (2021-2026)
Table 32. Global Biopharmaceutical Market Size Share by Application (2015-2020)
Table 33. Global Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 34. Global Biopharmaceutical Market Size Share by Application (2021-2026)
Table 35. North America Key Players Biopharmaceutical Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Biopharmaceutical Market Share (2019-2020)
Table 37. North America Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 38. North America Biopharmaceutical Market Share by Type (2015-2020)
Table 39. North America Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 40. North America Biopharmaceutical Market Share by Application (2015-2020)
Table 41. Europe Key Players Biopharmaceutical Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Biopharmaceutical Market Share (2019-2020)
Table 43. Europe Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Biopharmaceutical Market Share by Type (2015-2020)
Table 45. Europe Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Biopharmaceutical Market Share by Application (2015-2020)
Table 47. China Key Players Biopharmaceutical Revenue (2019-2020) (Million US$)
Table 48. China Key Players Biopharmaceutical Market Share (2019-2020)
Table 49. China Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 50. China Biopharmaceutical Market Share by Type (2015-2020)
Table 51. China Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 52. China Biopharmaceutical Market Share by Application (2015-2020)
Table 53. Japan Key Players Biopharmaceutical Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Biopharmaceutical Market Share (2019-2020)
Table 55. Japan Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Biopharmaceutical Market Share by Type (2015-2020)
Table 57. Japan Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Biopharmaceutical Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Biopharmaceutical Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Biopharmaceutical Market Share (2019-2020)
Table 61. Southeast Asia Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Biopharmaceutical Market Share by Type (2015-2020)
Table 63. Southeast Asia Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Biopharmaceutical Market Share by Application (2015-2020)
Table 65. India Key Players Biopharmaceutical Revenue (2019-2020) (Million US$)
Table 66. India Key Players Biopharmaceutical Market Share (2019-2020)
Table 67. India Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 68. India Biopharmaceutical Market Share by Type (2015-2020)
Table 69. India Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 70. India Biopharmaceutical Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Biopharmaceutical Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Biopharmaceutical Market Share (2019-2020)
Table 73. Central & South America Biopharmaceutical Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Biopharmaceutical Market Share by Type (2015-2020)
Table 75. Central & South America Biopharmaceutical Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Biopharmaceutical Market Share by Application (2015-2020)
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Product
Table 80. Roche Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 81. Roche Recent Development
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Product
Table 85. Amgen Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 86. Amgen Recent Development
Table 87. AbbVie Company Details
Table 88. AbbVie Business Overview
Table 89. AbbVie Product
Table 90. AbbVie Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 91. AbbVie Recent Development
Table 92. Sanofi-Aventis Company Details
Table 93. Sanofi-Aventis Business Overview
Table 94. Sanofi-Aventis Product
Table 95. Sanofi-Aventis Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 96. Sanofi-Aventis Recent Development
Table 97. Johnson & Johnson Company Details
Table 98. Johnson & Johnson Business Overview
Table 99. Johnson & Johnson Product
Table 100. Johnson & Johnson Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 101. Johnson & Johnson Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Product
Table 105. Pfizer Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 106. Pfizer Recent Development
Table 107. Novo Nordisk Company Details
Table 108. Novo Nordisk Business Overview
Table 109. Novo Nordisk Product
Table 110. Novo Nordisk Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 111. Novo Nordisk Recent Development
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Product
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 116. Eli Lilly Recent Development
Table 117. Novartis Company Details
Table 118. Novartis Business Overview
Table 119. Novartis Product
Table 120. Novartis Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 121. Novartis Recent Development
Table 122. Merck Company Details
Table 123. Merck Business Overview
Table 124. Merck Product
Table 125. Merck Revenue in Biopharmaceutical Business (2015-2020) (Million US$)
Table 126. Merck Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Erythropoietin Features
Figure 5. Insulin Features
Figure 6. Other Features
Figure 7. Global Biopharmaceutical Market Share by Application: 2020 VS 2026
Figure 8. Tumor Case Studies
Figure 9. Diabetes Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. Hemophilia Case Studies
Figure 12. Other Case Studies
Figure 13. Biopharmaceutical Report Years Considered
Figure 14. Global Biopharmaceutical Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Biopharmaceutical Market Share by Regions: 2020 VS 2026
Figure 16. Global Biopharmaceutical Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Biopharmaceutical Market Share by Players in 2019
Figure 19. Global Top Biopharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Biopharmaceutical Revenue in 2019
Figure 21. North America Biopharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Biopharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Biopharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Biopharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Biopharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Biopharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Biopharmaceutical Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
バイオ医薬品受託製造（BCMO）の世界市場（～2026年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biopharmaceutical Contract Manufa…- バイオ医薬品発酵システムの世界市場（～2026年） Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation. In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance …
- バイオ医薬品経口ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Biopharmaceutical Oral Drug Delivery Market The global Biopharmaceutical Oral Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biopharmaceutical Oral Drug Delivery Scop…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…